Results from several cross-sectional and retrospective studies highlight that CD is associated with a high frequency of rheumatoid factor-IgA (RF-IgA), implying the prevalence of RA in CD patients might be higher than in healthy controls (Fayyaz et al., 2019; Ghozzi et al., 2022). This evidence concerns the gene CD79A and rheumatoid arthritis.